Atlas Trials

Renoprotective Effects of Dapagliflozin in Type 2 Diabetes

Clinical trial NCT02682563 · COMPLETED

Trial details

NCT number
NCT02682563
Sponsor
M.H.H. Kramer
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2Diabetic Nephropathies
Start date
2016-02-01
Primary completion
2018-09-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.